Fractyl Health (GUTS) Revenue (2023 - 2024)
Fractyl Health (GUTS) recorded quarterly Revenue of $3000.0 in Q4 2024, down 78.57% on a QoQ basis from $14000.0 in Q3 2024, and down 57.14% YoY from $7000.0 in Q1 2024.
Powered by 
Analysis
Fractyl Health (GUTS) Revenue (2023 - 2024) Analysis & Trends
Fractyl Health (GUTS) has reported Revenue for 2 consecutive years, with $3000.0 the latest figure, recorded in Q4 2024.
- For the quarter ending Q4 2024, Revenue fell 57.14% year-over-year to $3000.0; the trailing twelve-month figure through Dec 2024 stood at $93000.0 (down 22.5% YoY), and the FY2024 full-year result was $93000.0, down 22.5% from the prior year.
- Revenue was $3000.0 for Q4 2024 at Fractyl Health, down from $14000.0 in the prior quarter.
- The five-year high for Revenue was $72000.0 in Q2 2023, with the low at $3000.0 in Q4 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.72 Bn | 175.11 Bn | 7.27 Bn | 12.59 Bn |
| 2 | Intuitive Surgical | 127.62 Bn | 122.40 Bn | 1.96 Bn | 2.89 Bn |
| 3 | Medtronic | 116.88 Bn | 108.07 Bn | 6.34 Bn | 9.76 Bn |
| 4 | Stryker | 103.99 Bn | 100.52 Bn | 4.50 Bn | 6.59 Bn |
| 5 | Boston Scientific | 63.65 Bn | 63.11 Bn | 3.85 Bn | 5.44 Bn |
| 6 | Edwards Lifesciences | 49.73 Bn | 45.48 Bn | 1.35 Bn | 1.74 Bn |
| 7 | Alcon | 33.00 Bn | 31.54 Bn | 1.68 Bn | 2.78 Bn |
| 8 | Dexcom | 32.03 Bn | 30.08 Bn | 830.00 Mn | 1.31 Bn |
| 9 | Steris | 20.70 Bn | 20.21 Bn | 684.20 Mn | 1.49 Bn |
| 10 | Fractyl Health | 102.69 Mn | 102.69 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | 3,000.00 |
| Sep 30, 2024 | 14,000.00 |
| Jun 30, 2024 | 43,000.00 |
| Mar 31, 2024 | 33,000.00 |
| Dec 31, 2023 | 7,000.00 |
| Sep 30, 2023 | 36,000.00 |
| Jun 30, 2023 | 72,000.00 |
| Mar 31, 2023 | 5,000.00 |